Article Listing - Biogen Idec 4th-qtr sales up 7% but earnings fall short of expectations

SOMBRE FUTURE FOR GENERALIST DRUG-MAKERS IN FRANCE?

9 March 1992

In contrast to specialist drug firms such as Innothera, which successfully exploit a niche in the drug market, generalist pharmaceutical...

ROCHE CENTER ESTABLISHED IN USA

9 March 1992

A new study center for nervous system injuries at Washington University in St Louis, Missouri, is being set up to...

TURNOVER UP 39% AT LUNDBECK UK

9 March 1992

In the UK, pharmaceutical concern Lundbeck says it is set for a healthy future following its latest annual results. For...

ROCHE TO PROMOTE GENENTECH'S DNase

9 March 1992

Swiss major Hoffmann-La Roche and Californian biotechnology concern Genentech last week announced four different international R&D agreements using their combined...

WARNING LETTER TO MILES ON NIMOTOP

9 March 1992

Promotion of the neurone-specific calcium channel blocker Nimotop (nimodipine) in the USA by Miles Laboratories for the unapproved indication of...

ORPHAN DRUG BILL FACES VETO

9 March 1992

Sponsors of legislation now in the Senate which would reduce the market monopoly enjoyed by orphan drug makers fear that...

MEDEVA'S NEW CORACTEN FORM

9 March 1992

Medeva plc and its subsidiary Evans Medical have launched in the UK a new product in the Coracten (nifedipine) range....

HUMAN CARCINOMA ANTIGEN

9 March 1992

Massachusetts-based company Epigen Inc has signed an agreement with investigators at the University of Oslo, Norway, to characterize the HC...

US APPROVAL FOR CARDENE SR

9 March 1992

Syntex Corp has received approval from the US Food and Drug Administration to market its Cardene SR, a slow-release formulation...

BIOCHEM PHARMA'S JOHN GILLARD

9 March 1992

John Gillard has been appointed as director of therapeutic research at BioChem Pharma Inc of Canada. 1614869 COST CONTAINMENT MEASURES...

Showing 94731-94740 of 95333 articles